Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
| Official URL: https://nshr-uat.sha.go.ke/fhir/ValueSet/nccp-condition-codes-vs | Version: 0.1.0 | ||||
| Active as of 2026-06-04 | Computable Name: ConditionCodesVS | ||||
ICD-10 diagnosis codes for common malignancies in Kenya.
References
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs version 📦0.1.0
Expansion performed internally based on codesystem Kenya Oncology Condition (ICD-10) Code System v0.1.0 (CodeSystem)
This value set contains 33 concepts
| System | Code | Display (en) | JSON | XML |
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C50 | C50 — Malignant neoplasm of breast | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C53 | C53 — Malignant neoplasm of cervix uteri | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C54 | C54 — Malignant neoplasm of corpus uteri | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C55 | C55 — Malignant neoplasm of uterus, part unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C56 | C56 — Malignant neoplasm of ovary | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C61 | C61 — Malignant neoplasm of prostate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C18 | C18 — Malignant neoplasm of colon | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C19 | C19 — Malignant neoplasm of rectosigmoid junction | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C20 | C20 — Malignant neoplasm of rectum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C15 | C15 — Malignant neoplasm of oesophagus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C16 | C16 — Malignant neoplasm of stomach | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C22 | C22 — Malignant neoplasm of liver and intrahepatic bile ducts | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C25 | C25 — Malignant neoplasm of pancreas | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C34 | C34 — Malignant neoplasm of bronchus and lung | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C32 | C32 — Malignant neoplasm of larynx | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C11 | C11 — Malignant neoplasm of nasopharynx | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C73 | C73 — Malignant neoplasm of thyroid gland | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C64 | C64 — Malignant neoplasm of kidney, except renal pelvis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C67 | C67 — Malignant neoplasm of bladder | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C43 | C43 — Malignant melanoma of skin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C71 | C71 — Malignant neoplasm of brain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C40 | C40 — Malignant neoplasm of bone and articular cartilage of limbs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C49 | C49 — Malignant neoplasm of connective and soft tissue | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C81 | C81 — Hodgkin lymphoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C83 | C83 — Non-follicular lymphoma (incl. Burkitt) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C85 | C85 — Other and unspecified types of non-Hodgkin lymphoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C90 | C90 — Multiple myeloma and malignant plasma cell neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C91 | C91 — Lymphoid leukaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C92 | C92 — Myeloid leukaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C46 | C46 — Kaposi sarcoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | C69 | C69 — Malignant neoplasm of eye and adnexa (incl. retinoblastoma) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | D05 | D05 — Carcinoma in situ of breast | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs | D06 | D06 — Carcinoma in situ of cervix uteri |